The global digital twin in healthcare market size is likely to be valued at US$7.6 billion in 2026, and is expected to reach US$73.2 billion by 2033, growing at a CAGR of 38.2% during the forecast period from 2026 to 2033, driven by the increasing prevalence of personalized medicine initiatives, rapid integration of AI/ML with patient-specific data models, growing demand for virtual simulation in surgical planning and drug discovery, and expanding adoption across hospitals, pharma companies, and medical device manufacturers. Increasing recognition of digital twins in healthcare as critical for precision therapeutics, virtual clinical trials, and operational efficiency in emerging value-based care and digital health ecosystems remains a major driver of market growth.